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MORINGA OLEIFERA LEAVES AQUEOUS EXTRACT INDUCE APOPTOSIS IN HT29
CELL LINE
Abstract
Moringa oleifera (MO) tree has been recognized for the nutritional and medicinal values, attributing antiinflammatory, antioxidants, and antidiabetic activities of the alcoholic and/or water extracts to its various
parts. Recent research has focused on therapeutic anti-cancerous effects of the water extract of MO
leaves (MOE), commonly consumed as hot beverage. In-vitro cytotoxicity on esophageal, lung, and breast
cancer cells were reported by MOE. The aim in this study is to investigate the anti-cancerous potential
of MOE on the colon carcinoma HT29 cells. MO water extract (MOE) was prepared at concentrations
(0.1%-0.5%). MOE anti-proliferative effect on HT29-cells was assessed by measuring cellular viability
using trypan blue assay. MOE cytotoxicity was further examined by monitoring the change in levels of
ROS (NBT assay), ATP (Luciferase assay), and LDH release (cytotoxicity assay) and on depolarization of
mitochondrial membrane potential (Mito PTTMJC-1). Protective effect of N-Acetyl cysteine and catalase
were assayed. Cell cycle analysis and Annexin-V/PI staining were also performed to detect cell death. Our
result showed that MOE induced a dose and time-dependent decrease in viability; increase in ROS and
LDH release; dissipation of mitochondrial membrane potential with concomitant decrease in ATP level. In
addition, we obtained an increase in preG0 and late apoptotic events. Pretreatment with the antioxidant
N-acetyl cysteine suppressed completely LDH release and restored partially and significantly cell viability
while decreasing ROS level. Catalase was not protective. MOE also induced cell death with related colon
cancer cell lines: Caco2, SW837, SW948, and HCT116. The induced apoptosis in HT29 cells and related
CCC identified MOE with anti-cancerous therapeutic potential.
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1. INTRODUCTION
Folk Medicine utilizes phytochemicals enriched drug formulation(s) that are derived from
plants and used in treatment of many ailments including cancer (Balunas & Kinghorn, 2005). World
health organization has recognized the importance of medicinal plants as curative as well as potential
source of therapeutic agents (World Health Organization, 1977). The interest in phytochemical
derived agents have increased significantly in the recent decades. The advantage of using the complex
mixture of plant extracts over synthetic drugs is their low cost and ability to target multiple sites
simultaneously, overcoming thus some of the reported side effects of drugs (Gurib-Fakim, 2006). In
addition, plant derived formulations may differ in composition, texture, and route of administration
depending on the mode and the extracting solvent that may yield emulsions, solids, liquids or oil.
Moringa oleifera L. (MO) referred to as the Miracle tree, or “Shagara al Rauwaq” belongs to
the Moringaceae family (Fahey, 2005; Goyal, et al., 2007; Anwar, et al., 2007). The National Institute
of Health has highlighted the importance of MO for its nutritive and medicinal values, as well as its
environmental detoxification ability (National Institutes of Health, 2008). All parts of the plant
including the seeds, leaves, roots, bark, flowers and pods, are edible and consumed by humans as raw,
cooked or boiled as drinks (Fuglie, 2001). Compared to other plant species, MO is richer (gram for
gram) in minerals, essential amino acids, vitamins, and a wide range of phytochemicals: sitosterols,
quercetin, kaempferol, glucosinolates, and isothiocyanates (Rockwood, et al., 2013; Manguro &
Lemmen, 2007; Ferreira, et al., 2008). Different pharmacological and biological activities have been
attributed to different parts of MO. For instance, different studies documented the anti-inflammatory
(Carceres, et al., 1992), anti-tumorigenic (Elsayed,, et al., 2015), and antimicrobial effects of MO
seeds (Eilert, et al.,1981; Madsen et al.,1987). Other studies performed on leaves extracted with
organic solvent showed hypocholesterolemic (Mehta et al., 2003), hypotensive (Gilani et al.,1994),
anti-ulcerative (Pal et al., 1995), anti-diabetic (Mbikay, 2012), and platelet aggregation inhibitory
(Arabshahi-Delouee et al., 2009) effects. In addition, to reported evidence in support of the possible
MO role in regulating blood sugar, and treating cardiovascular disorders (Singh et al.,2009), further
in vitro and in vivo studies with MO extracts demonstrated hepatoprotective (Sharifudin et al., 2013;
Pari & Kumar, 2002), neuroprotective (Ganguly & Guha, 2008), immunomodulatory (Sudha et al.,
2010; Mahajan & Mehta, 2010), diuretic (Carceres et al., 1992), antihypertensive (Faizi et al., 1995;
Faizi et al.,1998), and anti-carcinogenic effects (Ahmed et al., 2017).
Cancer is one of the main causes of deaths worldwide (World Health Organization, 2018).
Although many anti-cancerous drugs have been developed, yet the need to identify new drugs with
minimal side effects remains a priority in scientific research and pharmaceutical industries. The last
decade has witnessed the increase in the number of reports documenting evidence, though limited, of
the anti-proliferative effect of MO. Al-Asmari et al. investigated and compared the effects of alcoholic
extracts of MO bark, leaves and seeds on breast and colorectal cancerous cell lines (Al-Asmari et al.,
2015). Remarkable anti-cancerous effects were shown, mediated by the decrease in cell motility and
colony formation in: MDA-MB231 and HCT-8 treated with alcoholic leaves or bark extracts; while
the seed extracts’ exerted no effect. Another study using the alcoholic MO leaves’ extract documented
its cytotoxic, antioxidant and anti-proliferative effect on different cell lines: HepG2, Caco-2 and
MCF-7 (Charoensin, 2014). A similar profile was also obtained with MO leaves’ extract treated
ovarian and prostate human cancer cell lines (Zayas-Viera & Vivas-Mejia, 2016). Although MO is
widely used in traditional medicine, there is a limited number of studies on the anti-cancerous effect
of water extract of MO leaves (MOE) that is highly consumed by people as tea drink. Interestingly,
the toxicological evaluation of acute-oral administration of MOE showed it is safe (Awodele et al.,
2012) with no mortality occurring at a maximum dose of 2000 mg/kg (Adedapo et al., 2009). Hence
we opted in this study, to mimic people consumption of MO as tea beverage, (Madi et al., 2016) and
examine its anti-cancerous potential. In a recent study, we showed a dose dependent decrease in
viability of MOE-treated A549 cells (human lung adenocarcinoma), induced by compromised
mitochondrial function, increase in ROS level and PARP -1 cleavage (Madi et al., 2016).
In the current study, we focused on examining the effect of MOE, mimicking the commonly
consumed MO-tea drink by people, on colon cancer; one of the leading causes of death affecting
equally males and females. More specifically, we have investigated the effectiveness and anticancerous potential of MOE on HT29, a model of colon cancer cell (CCC) lines.
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2. MATERIALS AND METHODS
Moringa oleifera L. (MO) leaves were supplied by Salah Abdoun, agricultural engineer at
“Moringa Research and Development Group Farm”, in Khartoum, Sudan. The leaves were deposited
in the Post Herbarium at the American University of Beirut, under the Voucher number: “Usta 001”.
Leaves were aerated and dried at room temperature in the dark, then ground, and kept in dark glass
jars at 4oC. The cell line HT29, a generous gift from Dr. Ralph Abi-Habib, Department of Natural
Sciences, School of Arts and Sciences at the Lebanese American University, was originally purchased
from American Type Culture Collection (ATCC), Manassas, VA- USA. The following were supplied
by Sigma-Aldrich, (Missouri, USA): Roswell Park Memorial Institute Medium (RPMI, cat # R7388),
Dulbecco’s Modified Eagle’s Medium (DMEM cat # D5796), Heat inactivated fetal bovine serum
(FBS, cat # F9665), Phosphate Buffered Saline (PBS) solution (10X, cat # D1408), and TrypsinEDTA 1X-solution (cat # T3924), 0.4% Trypan Blue Solution (cat # T8154), antioxidants [Nacetylcysteine (NAC, cat # A9165); Catalase (cat # C3515)] and Propidium Iodide (PI, cat # P4170).
Penicillin-streptomycin (PEN-Strep mixture, cat # L0022-100) was purchased from Biowest.
The ATP Bioluminescence Assay Kit HS II (cat # 11 699 709 001), Cell Proliferation Kit I for
3-(4–5 dimethyl thiazol-2yl)-2, 5 diphenyl tetrazolium bromide (MTT) assay (cat # 11 465 007 001),
Cytotoxicity Detection Kit PLUS (LDH) (cat # 04 744 934001) were purchased from Roche,
Mannheim- Germany. Mito PTTMJC-1 kit (cat # ab113850) and Annexin-V FITC Apoptosis
Detection Kit (cat # ab14085) were purchased from Abcam (USA). P-Nitro Blue Tetrazolium
Chloride (NBT, cat # 6876) was purchased from MP chemicals, CA-USA.

2.1 Preparation of Moringa oleifera Water Extract (MOE)
Different concentrations of MOE were prepared by soaking the pulverized leaves (0.10.5g) in boiled dd-H2O (100ml) for 30 min with mild shaking. Extracts were then filtered,
centrifuged and supernatant was stored as 1ml aliquots at -20ºC.
Qualitative assessment of different phytochemicals was determined using the indicated
tests as described in previous reports: Lead acetate test, shinoda test, honey comb test and ferric
chloride test (Geetha, and Geetha, 2014); Copper acetate test (Tiwari et al., 2011); Tannic acid
test and gelatin test (Neelima, et al., 2010).

2.2 Culture of Colon Cancer Cell Lines
HT29 cells were cultured in humidified CO2 incubator at 37ºC in RPMI and supplemented
with fetal calf serum (10%) and Pen-Strep (0.5%). Other screened colon cancer cell lines were
cultured, under the same conditions, using RPMI for HCT116 cells and DMEM for Caco2,
SW837 and SW948.

2.3 Viability Assay
Viability of HT29 was determined using trypan blue exclusion assay in which dead cells
stains blue whereas viable cells remain white. HT29 cells were seeded in 12 well plates
(1×105cells/ml) and treated for 6 and 24hours with MOE at final well concentrations varying
from 0.01% to 0.05%. The % viability was determined by computing the ratio of viable cells in
treated to that of control (untreated cells) multiplied by 100.

2.4 Reactive Oxygen Species (ROS) Level
HT29 cells were seeded in 96 well plates (1x104/100µl) and treated with MOE at EC50
(0.03% determined by viability assay) for 3, 6, 12, and 24hours. The level of generated ROS was
determined as described previously (Muñoz et al., 2000). Briefly, NBT (1mg/ml,100μl) was
added to control and MOE treated HT29 cells, and incubated for 1hour. Cells were then washed
with methanol (100μl/well), and left to dry at room temperature. The formed formazan crystals
were solubilized by consecutive addition of KOH (2M, 120μl) and DMSO (140μl). Absorbance
of the developed color was read at 630 nm using Multiskan EX ELISA reader. % ROS generated
was calculated as follows:
% ROS production = 100 - % NBT
%NBT reduced = (Abs of MOE treated cells /Abs of control) ×100
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2.5 Lactate Dehydrogenase (LDH) Release
Cytotoxicity induced in MOE-treated HT29 cells was monitored using LDH release assay
kit (ROCHE). Disturbance in the plasma membrane integrity causes the release of cytoplasmic
LDH into the culture media. HT29 cells were seeded in 96 well plates (1x10 4cells/100µl), and
treated with MOE (0.03%) for 6 and 24hours. The % release of cytosolic LDH into the culture
media was determined by assessing the enzymatic conversion of tetrazolium salt into red
formazan, compared to 3-controls: cell free control, low control (spontaneous release of LDH),
and high control (maximum release of LDH). The intensity of developed color was read at 492
nm using Multiskan EX ELISA reader.
% LDH released: (Abs of treated cells - Abs of low control) X 100
(Abs of high control - Abs of low control)

2.6 Intracellular ATP Level
The intracellular ATP level was determined in both MOE-treated HT29 cells and untreated
control cells using the ATP Bioluminescence Assay Kit. Cells were seeded in 12-well plate
(1x105cells/1ml) and treated with MOE (0.03%) for 3, 6, 12, and 24hours. Subsequently, cells
were trypsinized, centrifuged, washed twice with 1X PBS, and lysed using the lysis reagent
provided by the kit. To 50μl of cell lysate (transferred to white MTP plates), Luciferase enzyme
(50µl) was added and Bioluminescence was measured using a luminometer (Fluoroscan Ascent
FL).
% ATP level = (Bioluminescence of treated cells/Bioluminescence control cells) X 100.

2.7 Mitochondrial Membrane Potential of MOE-treated Cells
The effect of MOE on the integrity of mitochondrial membrane in HT29 cells was assessed
using Mito PTTM JC-1 assay kit. Cells were seeded (l × l05cells/1ml) onto sterile glass cover slips
placed in 12-well plates and treated with MOE at EC50 (0.03%). Media was aspirated and cells
were incubated for 15 min at room temperature with 1x Mito PT TM JC-1 (300μl) stain solution
(provided by kit), then washed twice with buffer solution, and visualized using a ﬂuorescent
microscope (OLYMPUS; BH2-RFCA), at an excitation of 490 nm and emission of 510 nm.
Images were taken by OLYMPUS DP71 camera using the DP controller (OLYMPUS, 2001-2006;
3.1.1.267) acquisition software.

2.8 Cell Cycle Progression in MOE-treated HT29 Cells
Cell cycle progression was assessed using PI staining and flow cytometry. HT29 were
seeded in 100 mm petri dishes (1x106cells/10ml) and treated with MOE (0.03%) for 3, 6 and
24hours. Cells were then trypsinized, centrifuged (1500 rpm for 5 min), washed with PBS, fixed
in 70% ethanol (1d, -20ºC) then incubated at 4ºC (1hour) following the consecutive addition of
RNase A (100 μl, 200 μg/ml), PBS (350µl) and PI (35µl, 1mg/ml). The fluorescence of the PI
stained DNA was measured using Guava EasyCyte8 Flow Cytometer, collected as 10000 ungated
events and the corresponding cell cycle distribution according to DNA content was determined.

2.9 Annexin-V and Propidium Iodide Staining Assay
Annexin-V and propidium iodide (PI) staining was used to determine the mode of cell death
in MOE-treated HT29 cells. Briefly cells were seeded in 6- well plates (2×105cells/2 ml), treated
for 3, 6, and 24hours with MOE at EC50 (0.03%), trypsinized, washed with PBS, re-suspended (5
min) in Annexin-VFITC and PI containing binding buffer, at room temperature. The Annexin-V
FITC−/PI− cell population was considered normal, whereas the Annexin-V FITC+/PI− and
Annexin-V FITC+/PI+ were indicative of early and late apoptotic cells respectively. Flow
cytometry data were analyzed by the fluorescence Guava EasyCyte8 Flow Cytometer- Millipore.

2.10 Effect of Antioxidants on Viability, ROS, and LDH in MOE-treated HT29 Cells
The protective effect of NAC (5mM) and the enzyme catalase (3.4 U/ml) on MOE-treated
HT29 cells was examined. Cells were pretreated with either antioxidant, for 2hours prior to MOE
addition. Restoration of control viability, ROS, LDH levels were then determined as described
before.
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2.11 Effect of MOE on Related Colon Cancer Cells
Different colon cancer cell lines (HCT116, Caco2, SW837 and SW948) were treated with
MOE and compared with HT29 for viability as described before.

2.12 Statistical analysis
Results are reported as the mean ± standard error of the mean (SEM). Figure legends report
on the number of determinations from the different number of experiments. Significance was
determined using Microsoft Excel independent student t-test. p<0.05 were considered
significant. The inter-categorical statistical significance and the significance relative to the
control of each parameter were also analyzed by using independent student t-test.

3. RESULTS
Qualitative phytochemical analysis of the 1% Moringa oleifera (MOE) water extract identified
the presence of: flavonoids, saponins, di-terpenes, phenols, and alkaloids (Table 1). While tannins
were not detected in the 1% extract, they were identified in water extracts greater than 5% (Data not
shown).
Table 1: Phytochemical classes in MOE

Tests

Phytochemicals

1% MOE

Lead acetate Test

Flavonoids

+

Shinoda Test

Flavonoids

+

Honey Comb Test

Saponins

+

Copper Acetate Test

Diterpenes

+

FeCl3 Test

Phenols

+

Tannic Acid Test

Alkaloids

+

Gelatin Test

Tannins

-

3.1 MOE Decreased the Viability of HT29 Cells
MOE decreased in a dose dependent manner the viability of HT29 cells. Treating cells for
6 hours with increasing MOE concentration caused significant (p<0.001) cell death (Figure 1A).
Estimated EC50 was obtained at 0.03% with further decrease in viability reaching 70% at 0.05%.
A similar dose dependent decrease in viability profile was obtained after 24 hours reaching 98%
cell death at 0.05% MOE (Figure 1A).

3.2 MOE-Treated HT29 Cells Induced LDH Release
The integrity of plasma membrane was assessed by quantifying the level of LDH released
from MOE-treated (0.03%) HT29 cells into culture media. The level of released LDH increased
from 8% (p<0.01) to 48% (p<0.001) post MO-treatment for 6 and 24 hours respectively (Figure
1B).

3.3 Time Dependent Increase in ROS Level in MOE Treated HT29 Cells
Treatment of HT29 with MOE (EC50) resulted in a time dependent gradual increase in
ROS level. A significant increase in ROS level of 14.7% and 53% (p < 0.001) was obtained at
3hours and 24hours post treatment respectively (Figure 1C).
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Fig. 1: Effect of MOE-treated HT29 cells on A) Viability using trypan blue exclusion assay. B) LDH
released level C) Changes in ROS level with time. Data presented are the mean ± SEM of 9
determinations of three different experiments. Asterisks on bars represent significance relative to the
control, *P<0.05, **P<0.01, and ***P<0.001 respectively.

3.4 MOE DECREASED ATP LEVEL AND DISSIPATED MITOCHONDRIAL
MEMBRANE POTENTIAL IN HT29 CELLS
The effect of MOE-treated HT29 cells on mitochondrial function was assessed by
monitoring changes in ATP level, and membrane potential.
MOE caused a time dependent decrease in ATP level (Figure 2A). A significant decrease
of 42% (p<0.01) occurred after 6hours of treatment; with further decrease reaching 91%
(p<0.001) at 24hours at EC50. It is known that dissipation of mitochondrial membrane potential
would decrease ATP level. To verify whether the drop in ATP level at 6hours is consequent to
dissipation of membrane potential we examined the effect of MOE on membrane potential at an
earlier time point. Using Mito-JC1, healthy control cells stained red orange, whereas MOEtreated HT29 cells showed increase in green stain indicating dissipation of mitochondrial
membrane potential starting at 3hours (Figure 2B).

Fig.2: Effect of MOE-treated HT29 on: A) Changes in ATP level with time using ATP Bioluminescence
Assay. Data presented is the mean ± SEM of 6 determinations from three different experiments. Asterisks
on bars represent significance relative to the control. **P<0.01, and ***P<0.001 respectively. B)
Mitochondrial Membrane Potential using MitoPT TM JC-1 kit; a representative image of 3 different
experiments.
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3.5 Cell Cycle Analysis of MOE Treated HT29 Cells
We next examined the changes in cell cycle phases in MOE treated HT29 cells. Cell
phases were analyzed over different time intervals: 3, 6, and 24hours (Figure 3). Compared to
control cells, MOE treated HT29, showed a significant increase (3.6 fold) with time in preG0
phase concomitant with a decrease (0.4 fold) in G2M phase. No significant fold change was
detected in G0G1 or S-Phases (Figure 3C).

Fig.3: Distribution of cell cycle phases in MOE-treated HT29 with time using PI flow cytometry. A)
Representative figure of the variation in phases with time B) Representative histogram of the effect of
MOE, at different time point. C) Fold change in cell cycle phases. Data presented are the mean ± SEM of 3
different experiments.

Next, to examine whether cell death is apoptotic or necrotic, the effect of MOE-treated
HT29 was determined at 3, 6, and 24hours (Figure 4) using Annexin V-FITC PI staining. A
significant increase in the percentage of cells in the late apoptosis (3 to 9-fold) was obtained,
while the change of those that are undergoing necrosis was less significant (3.5 to 4.4 fold) at 3
and 24 hours respectively (Figure 4B).

Fig.4: Apoptosis assessment in MOE-treated HT29 cells with time (3, 6 and 24hours) using Annexin-V PI:
A) Representative image from one experiment. B) Fold change in cellular phase distribution in MOE treated
HT29 compared to control cells at different times. Data presented is the mean ± SEM the mean of 3 different
experiments.
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3.6 Protective Effect of NAC But Not Catalase
The protective effect of the antioxidants NAC and catalase in MOE-treated HT29 cells at
EC50 (0.03%) was investigated (Figure 5). MOE induced cytotoxicity in HT29 cells.
Pretreatment with NAC increased significantly the viability (50%-75%) (Figure 5A), decreased
generated ROS level (Figure 5B), and completely suppressed (p<0.001) the MOE induced LDH
release (from 52.8% to 2.8%) as shown in Figure 5C. Catalase on the other hand was less
effective than NAC and showed variable effects on the HT29 cell line. It caused minimal
increase/restoration (10%) in viability (Figure 5A), did not decrease ROS production (Figure
5B) and with no effect on LDH release (Figure 5C).

Fig.5: Effect of NAC and catalase pre-treatment on MOE-treated HT29 cells on (A) Viability, (B) ROS, (C)
LDH release. Cells were pre-treated with NAC (5mM), or catalase (3.4U/ml) for 2hours, prior to MOE
treatment. Data presented is the mean ± SEM of 9 determinations from three different experiments. Asterisks
on bars represent significance relative to the EC50 (0.03%). *P< 0.05, **P<0.01, and ***P<0.001
respectively.

3.7 MOE Effect on Cell Viability of Other Colon Cancer Cell Lines
The effect of MOE on related colon cancer cell (CCC) lines was examined. Cells tested
included HCT116, Caco2, SW837 and SW948.The Estimated EC50 were: 0.02% HCT116 and
Caco2; 0.01% for SW837 and 0.03% for SW948 (Table 2).

Table 2: Estimated EC50 of MOE-treated CCC
Cell Lines

Estimated EC50

HCT116

0.02%

Caco2

0.02%

SW837

0.01%

SW948

0.03%
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4. DISCUSSION
Interest in identifying novel natural drugs that are toxic to cancerous, but not to normal cells,
have increased in the recent years in traditional medicine. Plants extracts have been used in the
treatment of many ailments providing a source of low cost phytochemicals with effective therapeutic
potential.
Moringa oleifera has been recognized for its biological activity targeting multicellular sites and
therapeutic values including anti-cancer (Charoensin, 2014).
In this study, we have examined the anti-cancerous potential of MOE on HT29 cells; a model
of intestinal epithelium human colon cancer cell lines (CCC) (De Luca et al., 2014). We hereby show,
a dose dependent cytotoxic effect on MOE-treated HT29. MOE-induced cell death by: increasing
ROS level and depolarizing in mitochondrial membrane potential (3hours), followed by a decrease in
ATP level (6hours), at 24hours we obtained an increase in cell cycle preG0 phase and in late apoptotic
events, with concomitant increase in LDH release (biomarker of necrotic event). Pre-treatment with
anti-oxidant N-acetyl cysteine suppressed completely LDH release and significantly restored partial
viability. We also tested the effect of MOE on other cell lines and they showed to be sensitive to
treatment at different concentrations.
In this study we opted to use water extract of MO despite the fact that concentration of extracted
compound in organic solvents are much higher. Our aim was to mimic people consumption of MO
leaves as herbal tea and studying its potential anti-cancerous effect. Previous studies have reported
that aqueous Moringa leaf extracts are safe at high doses (Awodele et al., 2012). A perceptible dose
and time dependent increase in cell death as for 6hours was obtained in MOE-treated HT29 cells with
further increase at 24hours (Figure 1A). Our results are in agreement with previous reports on HepG2
(Jung IL et al., 2015), A549 (Madi et al., 2016; Jung IL et al., 2015), HCT116 (Reda et al., 2017),
and KB (Sreelatha & Padma, 2011) cancerous cell lines.
Reactive oxygen species (ROS) are one of the important regulators of cell death and survival
mechanisms (Raza et al., 2017). Following treatment with MOE, we obtained an early increase in
oxidative stress (ROS) occurred as of 3 hours becoming incompatible with cell viability at 24hours
(Figure 1C). A major source of ROS is the electron transport chain of mitochondria. The increase in
ROS following MOE-treated HT29 was accompanied by an increase in mitochondrial membrane
depolarization that was further confirmed by a decrease in ATP level at 6hours (Figure 2 A & B).
Further decrease in ATP level was obtained at 24hours (Figure 2A).
MOE-induced cytotoxicity however is not limited to derangement in mitochondrial membrane
potential but it influenced as well the plasma membrane. A biomarker of damaged plasma membrane
is associated with an increase in released lactate dehydrogenase extracellularly resulting from
increased membrane permeability. In our study, LDH release was minimal after 6hours’ treatment of
MOE but reached maximum of 50% after 24hours (Figure 1B) indicating a possible necrotic effect.
To examine whether it is necrotic or apoptotic, quantitative analysis with time showed an increase in
PreG0 (Cell cycle) and late apoptotic events with no time dependent variation in necrotic effect
(Annexin-V PI) (Figure 3 and Figure 4). This was further confirmed following pretreatment with
NAC, a GSH precursor which suppressed completely LDH release and restored partially and
significantly cell viability indicating it is apoptotic rather than necrotic (Figure 5) and that the LDH
released is considered as secondary necrosis due to apoptotic cells (caspase activity measured, data
not shown).
It is possible to suggest that the complete suppression of LDH release, and significant
restoration of viability and ROS level) may be attributed to: a) promoting biosynthesis of intracellular
GSH which decreases ROS and reverses induced cell death mechanism; b) interacting directly with
thiol containing intracellular and plasma membrane bound proteins involved in the MOE induced
cell death; and c) neutralizing the pro-oxidant potential of MOE components at the expense of itself
getting oxidized. Regardless whether one or all of the possibilities are involved, the net result led to
a protective effect against the induced cell death. On the other hand, pretreatment with catalase, a
hydrogen peroxide metabolizing enzyme, exerted a minimal restoration in viability of HT29 cells
(Figure 5), while had no effect on ROS and LDH levels indicating that H2O2 is not a major key player
in the induced cytotoxicity of MOE.
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5. CONCLUSION
To sum up we hereby report the potential anti-cancerous effect of MOE on HT29 cell line and
related CCC. MOE-induced cell death by simultaneous increase in intracellular oxidative stress and
dissipation of mitochondrial membrane potential leading to decrease of ATP level and increase in
plasma membrane permeability, suppression of LDH release by NAC pretreatment favors apoptotic
rather than necrotic effect (Figure 6). Both cell cycle analysis and annexin-V PI results were
confirmatory the extract-induced apoptotic events occurred in HT29 cells as well as related CCC
suggest therapeutic potential of MOE in preventing or treating cancer.

Fig.6: A schematic chart summarizing the apoptotic events occurring in MOE-treated HT29 colon cancer cells

6. ACKNOWLEDGMENT
The authors acknowledge the American University of Beirut for partially supporting this study.

REFERENCES







Adedapo, A. A., Mogbojuri, O. M., & Emikpe, B. O. (2009). Safety evaluations of the aqueous
extract of the leaves of Moringa oleifera in rats. Journal of Medicinal Plants Research, 3(8),
586-591.
Ahmed A. Abd-Rabou, Aboelfetoh, M., Abdalla, Naglaa, A. Ali, & Khairy, M.A. Zoheir (2017).
Moringa oleifera Root Induces Cancer Apoptosis More Effectively than Leave Nanocomposites
and Its Free Counterpart. Asian Pacific Journal of Cancer Prevention: APJCP, 18(8), 2141–
2149.
Al-Asmari, A. K., Albalawi, S. M., Athar, M. T., Khan, A. Q., Al-Shahrani, H., & Islam, M.
(2015). Moringa oleifera as an anti-cancer agent against breast and colorectal cancer cell
lines. PloS one, 10(8), e0135814.
Anwar, F., Latif, S., Ashraf, M., & Gilani, A. H. (2007). Moringa oleifera: a food plant with
multiple medicinal uses. Phytotherapy Research: An International Journal Devoted to
Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 21(1), 17-25.
Arabshahi-Delouee, S., Aalami, M., Urooj, A., & Krishnakantha, T.P. (2009). Moringa oleifera
leaves as an inhibitor of human platelet aggregatiom. Pharmaceutical Biology, 47(8), 734-739.

Published by Digital Commons @ BAU, 2020

9

BAU Journal - Science and Technology, Vol. 2, Iss. 1 [2020], Art. 7























Awodele, O., Oreagba, I.A., Odoma, S., Taxiera da Silva, J.A., & Osunkalu, V.O. (2012).
Toxicological evaluation of the aqueous leaf extract of Moringa oleifera Lam (Moringaceae).
Journal of Ethnopharmacology, 139, 330-336.
Balunas, M.J., & Kinghorn, A.D. (2005). Drug discovery from medicinal plants. Life Sciences,
78, 431-441.
Carceres, A., Sariva, A., Rizzio, S., Zabala, L., De Leon, E., & Navy, F. (1992). Pharmacological
properties of Moringa oleifera. 2: screening of antispasmodic, anti-inflammatory and diuretic
activity. Journal of Ethnopharmacol, 36(3), 233-237.
Charoensin, S. (2014). Antioxidant and anticancer activities of Moringa oleifera leaves. Journal
of Medicinal Plants Research, 8(7), 318-325.
De Luca, P., Arnaboldi, F., Maggioni, M., Donetti, E., Fiorilli, A., & Ferraretto, A. (2014).
Morphology related functionality in Caco2/HT-29 co-culture cells: a versatile model of human
intestinal epithelium. Italian Journal of Anatomy and Embryology, 119(1), 1.
Eilert, U., Wolters, B., & Norsdtedt, A. (1981). The antibiotic principle of seeds of Moringa
oleifera and moringa stenopetala. Planta med, 42(1), 55-61.
Elsayed, E. A., Sharaf-Eldin, M. A., & Wadaan, M. (2015). In vitro evaluation of cytotoxic
activities of essential oil from Moringa oleifera seeds on HeLa, HepG2, MCF-7, CACO-2 and
L929 cell lines. Asian Pac. J. Cancer Prev, 16, 4671-4675.
Fahey, J. W. (2005). Moringa oleifera: a review of the medical evidence for its nutritional,
therapeutic, and prophylactic properties. Part 1. Trees for life Journal, 1(5), 1-15.
Faizi, S., Siddiqui, B.S., Saleem, R., Siddiqui, S., Aftab, K., & Gilani, A.H. (1995). Fully
acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera.
Phytochemistry, 38, 957-963.
Faizi, S., Siddiqui, B.S., Saleem, R., Aftab, K., Shaheen, F., & Gilani, A.H. (1998). Hypotensive
constituents from the pods of Moringa oleifera. Planta Med, 64, 225-228.
Ferreira, P. M. P., Farias, D. F., Oliveira, J. T. D. A., & Carvalho, A. D. F. U. (2008). Moringa
oleifera: bioactive compounds and nutritional potential. Revista de Nutrição, 21(4), 431-437.
Fuglie, L.J. (2001). The Miracle Tree: Moringa oleifera: natural nutrition for the tropics church
world service, Dakar. Revised in and published as the miracle tree: The Multiple Attributes of
Moringa, 68, 172.
Ganguly, R., & Guha, D. (2008). Alteration of brain monoamines and EEG wave pattern in rat
model of Alzheimer’s diseases and protection by Moringa oleifera. Indian J Med Res, 128, 744751.
Geetha, T.S., & Geetha, N. (2014). phytochemical screening, quantitative analysis of primary
and secondary metabolites of Cymbopogan citratus (DC) stapf. Leaves from koaikanal hills,
Tamilnadu, International Journal of Pharmtech Research, 521-529
Gilani, A.H., Aftab, K., Suria, A., Siddiqui, S., Salem, R., & Siddiqui, B.S. (1994).
Pharmacological studies on hypotensive and spasmolytic activities of pure compounds from
Moringa oleifera. Phytother Ressearch, 8(2),87-91.
Goyal, B.R., Agraval, B.B., Goyal, R.K., & Mahta, A.A. (2007). Phyto-pharmacology of
Moringa oleifera Lam an overview. Nat Prod Rad, 6, 347-353.
Jung, IL., Lee, JH., & Kang, SC. (2015). A potential oral anticancer drug candidate, Moringa
oleifera leaf extract, induces the apoptosis of human hepatocellular carcinoma cells. Oncology
Letter, 10, 1597-1604.
Madi, N., Dany, M., Abdoun, S., & Usta, J. (2016). Moringa oleifera's nutritious aqueous leaf
extract has anticancerous effects by compromising mitochondrial viability in an ROS-dependent
manner. Journal of the American College of Nutrition, 35(7), 604-613.
Madsen, M., Schlundt, J., & El Fadil, E. O. (1987). Effect of water coagulation by seeds of
Moringa oleifera on. Journal of Tropical Medicine and Hygiene, 90, 101-109.
Mahajan, S.G., & Mehta, A.A. (2010). Immunosuppressive activity of ethanolic of seeds of
Moringa oleifera Lam. In experimental immune inflammation. Journal of Ethnopharmacol, 130,
183-186
Manguro, L.O., & Lemmen, P. (2007). Phenolics of Moringa leaves. Nat Prod Res, 21(1), 5668.

https://digitalcommons.bau.edu.lb/stjournal/vol2/iss1/7

10

Reda et al.: MORINGA OLEIFERA LEAVES AQUEOUS EXTRACT INDUCE APOPTOSIS IN HT29





















Mbikay, M. (2012). Therapeutic Potential of Moringa oleifera Leaves in Chronic
Hyperglycemia and Dyslipidemia: A Review. Front Pharmacol, 3, 24.
Mehta, L.K., Balaraman, R., Amin, A.H., Bafna, P.A., & Gulati, O.D. (2003). Effect of fruits of
Moringa Oliefera on the lipid profile of normal and hypercholesterolemic rabbits. Journal of
Ethnopharmacology, 86(2-3),191-195
Muñoz, M., Cedeño, R., Rodríguez, J., van der Knaap, W.P.W., Mialhe, E., & Bachère, E.
(2000). Measurement of reactive oxygen intermediate production in haemocytes of the penaeid
shrimp, Penaeus vannamei. Aquaculture, 191, 89–107.
National Institutes of Health (2008). NIH Celebrates Earth Day. Retrieved from www.nih.gov
Neelima, N., Devidas, N., Sudhakar, M., & Kiran V, J. (2011). A Preliminary Phytochemical
Investigation on the Leaves of Solanum Xanthocarpum. International Journal of Research in
Ayurveda & Pharmacy, 846.
Pal, S.K., Mukherjee, P.K., & Saha, P. (1995). Studies on the anti-ulcer activity of Moringa
oleifera leaf extract on gastric ulcer models in rats. Phytother Research, 9(6),463-465.
Pari, L., & Kumar, N. A. (2002). Hepatoprotective activity of Moringa oleifera on antitubercular
drug-induced liver damage in rats. Journal of Medicinal Food, 5(3), 171-177.
Raza, M. H., Siraj, S., Arshad, A., Waheed, U., Aldakheel, F., Alduraywish, S., & Arshad, M.
(2017). ROS-modulated therapeutic approaches in cancer treatment. Journal of Cancer Research
and Clinical Oncology, 143(9), 1789-1809.
Fakhouri, R., Usta, J., Reda, F., & Borjac, J. (2015, November). Cytotoxic effect of Moringa
oleifera on colon cancer cell lines. In I International Symposium on Moringa 1158 (pp. 269278).
Rockwood, J.L., Anderson, B.G., & Casamatta, D.A. (3013). Potential uses of Moringa oleifera
and an examination of antibiotic efficacy conferred by M. oleifera seed and leaf extracts using
crude extraction techniques available to underserved indigenous populations. International
Journal of phytotherapy Research, 3, 61-71.
Sharifudin, S.A., Fakurazi, S., Hidayat, M.T., Haruszah, I., Aris MohdMoklas, M., & Arulselvan,
P. (2013). Therapeutic potential of Moringa oleifera extracts against acetaminophen –induced
hepatotoxicity in rats. Pharm Biol, 51, 279-288
Singh, B.N., Singh, B.R., Singh, R.L., Prakash, D., Dhakarey, R., Upadhyay, G., & Singh, H.B.
(2009). Oxidative DNA damage protective activity antioxidant and anti-quorum sensing
potentials of Moringa oleifera. Food and Chemical Toxicology, 47, 1109-1116.
Sreelatha, S., & Padma, P. R. (2011). Modulatory effects of Moringa oleifera extracts against
hydrogen peroxide-induced cytotoxicity and oxidative damage. Human & Experimental
Toxicology, 30(9), 1359-1368.
Sudha, P., Asdaq, S.M., Dhamingi, S.S., & Chandrakala, G.K. (2010). Immunomodulatory
activity of methanolic leaf extract of Moringa oleifera in animals. Indian J Physiol Pharmacol,
54(2), 133-140.
Tiwari, P., Kumar, B., Kaur, M., Kaur, G., & Kau, H. (2011). Phytochemical screening and
Extraction: A Review, International Pharmaceutica Sciencia, Page 104.
World Health Organization, WHO 1977.
World Health Organization, WHO 2018.
Zayas-Viera, M.D.M., & Vivas-Mejia, P.E. (2016). Anticancer effect of Moringa oleifera leaf
extract in Human Cancer cell lines. Journal of Health Disparities Research and Practice, 9, 141142.

Published by Digital Commons @ BAU, 2020

11

